颅内动脉瘤再出血危险因素的研究进展(5)
[23]Starke RM，Connolly ES Jr.Participants in the international multi-disciplinary consensus conference on the critical care management of subarachnoid hemorrhage.Rebleeding after aneurysmal subarachnoid hemorrhage[J].Neurocrit Care，2011，15(2)：241-246.
[24]Boogaarts HD，van Lieshout JH，van Amerongen MJ，et al.Aneurysm diameter as a risk factor for pretreatment rebleeding：a meta-analysis[J].J Neurosurg，2015，122(4)：921-928.
[25]Aikawa H，Kazekawa K，Nagata S，et al.Rebleeding after endovascular embolization of ruptured cerebral aneurysms[J].Neurol Med Chir (Tokyo)，2007，47(10)：439-445.
[26]Connolly ES，Rabinstein AA，Carhuapoma JR，et al.Guidelines for the management of aneurysmal subarachnoid hemorrhage： a guideline for healthcare professionals from the American Heart Association/american Stroke Association[J].Stroke，2012，43(6)：1711-1737.
[27]Yin C，Huang GF，Ruan J，et al.The APOE promoter polymorphism is associated with rebleeding after spontaneous SAH in a Chinese population[J].Gene，2015，563(1)：52-55.
[28]Foreman PM，Starke RM，Hendrix P，et al.Endothelin polymorphisms as a risk factor for cerebral aneurysm rebleeding following aneurysmal subarachnoid hemorrhage[J].Clin Neurol Neurosurg，2017，157：65-69.
[29]Petridis AK，Kamp MA，Cornelius JF，et al.Aneurysmal subarachnoid hemorrhage[J].Dtsch Arztebl Int，2017，114(13)：226-236.
(收稿日期：2017-07-10 本文編辑：祁海文), 百拇医药(张逸夫 向本友)
[24]Boogaarts HD，van Lieshout JH，van Amerongen MJ，et al.Aneurysm diameter as a risk factor for pretreatment rebleeding：a meta-analysis[J].J Neurosurg，2015，122(4)：921-928.
[25]Aikawa H，Kazekawa K，Nagata S，et al.Rebleeding after endovascular embolization of ruptured cerebral aneurysms[J].Neurol Med Chir (Tokyo)，2007，47(10)：439-445.
[26]Connolly ES，Rabinstein AA，Carhuapoma JR，et al.Guidelines for the management of aneurysmal subarachnoid hemorrhage： a guideline for healthcare professionals from the American Heart Association/american Stroke Association[J].Stroke，2012，43(6)：1711-1737.
[27]Yin C，Huang GF，Ruan J，et al.The APOE promoter polymorphism is associated with rebleeding after spontaneous SAH in a Chinese population[J].Gene，2015，563(1)：52-55.
[28]Foreman PM，Starke RM，Hendrix P，et al.Endothelin polymorphisms as a risk factor for cerebral aneurysm rebleeding following aneurysmal subarachnoid hemorrhage[J].Clin Neurol Neurosurg，2017，157：65-69.
[29]Petridis AK，Kamp MA，Cornelius JF，et al.Aneurysmal subarachnoid hemorrhage[J].Dtsch Arztebl Int，2017，114(13)：226-236.
(收稿日期：2017-07-10 本文編辑：祁海文), 百拇医药(张逸夫 向本友)